Technical Analysis for CGEN - Compugen Ltd.

Grade Last Price % Change Price Change
grade C 3.45 -0.29% -0.01
CGEN closed down 0.29 percent on Monday, May 20, 2019, on 63 percent of normal volume. It was able to bounce off of its 200 day moving average, an important long-term support line. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Down Down
See historical CGEN trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
200 DMA Support Bullish 0.00%
Hammer Candlestick Bullish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Earnings Movers Other 0.00%
BB Squeeze + Lower Band Touch Range Contraction 0.00%
Outside Day Range Expansion 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Crossed Above 200 DMA Bullish -0.29%
Bollinger Band Squeeze Range Contraction -0.29%

Older signals for CGEN ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Compugen Ltd., a therapeutic product discovery company, engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates primarily in the United States, Europe, and Israel. It focuses on the therapeutic proteins and monoclonal antibodies to address unmet needs in the fields of immunology and oncology. The company's therapeutic proteins pipeline includes CGEN-15001, a novel protein for the treatment of autoimmune disorders; CGEN-15021, a novel fusion protein for the treatment of multiple sclerosis, rheumatoid arthritis, and other autoimmune diseases; CGEN-15091, a novel fusion protein for the treatment of multiple sclerosis and autoimmune diseases; CGEN-15031, a fusion protein candidate to treat multiple sclerosis; and CGEN-15051, a fusion protein candidate for the treatment of rheumatoid arthritis. Its monoclonal antibody therapy product candidates include CGEN-15001T, a membrane protein target for the treatment of cancer; CGEN-15022 membrane protein for the treatment of multiple cancers; CGEN-671, a novel drug target for the treatment of multiple epithelial tumors; and CGEN-928 drug target for the treatment of multiple myeloma. Compugen Ltd. was founded in 1993 and is headquartered in Tel Aviv, Israel.
Medicine Biopharmaceutical Cancer Medical Specialties Life Sciences Immunology Treatment Of Cancer Antibodies Cancers Autoimmune Diseases Multiple Sclerosis Rheumatoid Arthritis Antibody Multiple Myeloma Monoclonal Antibody Autoimmunity Autoimmune Disorders Compugen Treatment Of Multiple Sclerosis Antibody Therapy Fusion Protein
Is CGEN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 4.31
52 Week Low 2.0
Average Volume 159,850
200-Day Moving Average 3.425
50-Day Moving Average 3.6864
20-Day Moving Average 3.4915
10-Day Moving Average 3.503
Average True Range 0.1644
ADX 21.65
+DI 12.5723
-DI 21.9884
Chandelier Exit (Long, 3 ATRs ) 3.1668
Chandelier Exit (Short, 3 ATRs ) 3.7732
Upper Bollinger Band 3.5979
Lower Bollinger Band 3.3851
Percent B (%b) 0.3
BandWidth 6.094802
MACD Line -0.0537
MACD Signal Line -0.0577
MACD Histogram 0.004
Fundamentals Value
Market Cap 176.41 Million
Num Shares 51.1 Million
EPS -0.67
Price-to-Earnings (P/E) Ratio -5.15
Price-to-Sales 1330.24
Price-to-Book 3.46
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.79
Resistance 3 (R3) 3.79 3.66 3.74
Resistance 2 (R2) 3.66 3.58 3.67 3.72
Resistance 1 (R1) 3.56 3.52 3.49 3.56 3.70
Pivot Point 3.43 3.43 3.40 3.44 3.43
Support 1 (S1) 3.33 3.35 3.27 3.34 3.20
Support 2 (S2) 3.20 3.29 3.21 3.18
Support 3 (S3) 3.10 3.20 3.16
Support 4 (S4) 3.11